endometriosis
ENDOMETRIOSIS

Endometriosis is an estrogen-dependent growth of extrauterine endometrial-like tissue that induces a chronic inflammatory response.

Main clinical features include chronic pelvic pain, dyspareunia and infertility.

Patients with endometriosis may also be completely asymptomatic.

Goals of treatment are decreasing pain, enhancing fertility, and preventing progression or recurrence. 

 

Endometriosis Drug Information

Drug Information

Indication: Dysmenorrhoea, endometriosis, secondary amenorrhoea, irregular cycles, dysfunctional uterine bleeding, pre-men...

Indication: Locally advanced or metastatic prostate cancer. Genital & extragenital stage I-IV endometriosis. Precociou...

Dosage:  Hormone replacement therapy for women w/ disorders due to natural or surgically induced menopause w/ intact u

Indication: Premenstruation syndrome, postponement of menstruation, mastodynia, cycle disturbance associated w/ shortening...

Indication: Disorders associated w/ progesterone deficiency eg, infertility due to inadequate luteal phase; for use during...

Indication: Premenstrual syndrome (PMS) including premenstrual tension & depression. Luteal phase support as part of a...

Indication: Complaints resulting from natural or artificial menopause. Prevention of osteoporosis in postmenopausal women ...

Indication: Amenorrhea, abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology eg, submuc...

Indication: Complaints resulting from natural or artificial menopause. Prevention of osteoporosis in postmenopausal women ...

Indication: Management of prostate cancer, breast cancer in premenopausal & perimenopausal women suitable for hormonal...

1  /  3
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 21 Oct 2020

NT-814, an oral, non-hormonal dual neurokinin 1,3 receptor antagonist may reduce the frequency of hot flashes, while improving quality of life (QoL) and sleep in postmenopausal women, according to results of the phase IIb SWITCH-1 trial presented at NAMS 2020.